Skip to main content
Back
Watch Compare

REVELATION BIOSCIENCES, INC.

Data quality: 83%
Also listed as REVBW Nasdaq
REVB
Nasdaq Manufacturing Chemicals
$1.23
▲ $0.02 (1.65%)
Mkt Cap: 4.58 M
Price
$1.23
Mkt Cap
4.58 M
Day Range
$1.19 — $1.28
52-Week Range
$1.06 — $44.16
Volume
62,481
Open $1.22
50D / 200D Avg
$1.43
14.23% below
50D / 200D Avg
$5.50
77.62% below

Quick Summary

Key Takeaways

Negative free cash flow of -8.29 M

Growth

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Quality

Return on Equity
-120.23%
Below sector avg (-53.41%)
ROIC-96.66%
Net MarginN/A
Op. MarginN/A

Safety

Debt / Equity
N/A
Current Ratio6.92
Interest CoverageN/A

Valuation

PE (TTM)
-0.51
Above sector avg (-1.48)
P/B Ratio0.42
EV/EBITDAN/A
Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Manufacturing sector median (1364 peers)
Metric Stock Sector Median
P/E -0.5 -1.5
P/B 0.4 1.6
ROE % -120.2 -53.4
Net Margin % — -41.5
Rev Growth 5Y % — 1.8
D/E — 0.3

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -8.91 M
ROE -120.23% ROA -97.68%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -8.29 M
ROIC -96.66% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 6.92
Interest Coverage N/A Asset Turnover N/A
Working Capital 10.98 M Tangible Book Value 11.00 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -0.51 Forward P/E N/A
P/B Ratio 0.42 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -181.13%
Market Cap 4.58 M Enterprise Value -8.13 M
Per Share
EPS (Diluted TTM) -23.95 Revenue / Share N/A
FCF / Share -2.23 OCF / Share -2.22
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 92.99%
SBC-Adj. FCF -8.55 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue — — — — —
Net Income -8.91 M -15.04 M -120,254.0 -10.83 M -2.13 M
EPS (Diluted) -23.95 -87.68 -0.53 -20.09 —
Gross Profit — — — — —
Operating Income -9.07 M -7.98 M -8.66 M -10.86 M —
EBITDA — — — — —
R&D Expenses 4.06 M 3.55 M 4.15 M 5.38 M —
SG&A Expenses — — — — —
D&A — — — — —
Interest Expense — — — — 41,759.0
Income Tax 0.0 0.0 0.0 0.0 —

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 11.58 M 6.62 M 12.21 M 5.50 M 48.39 M
Total Liabilities 2.72 M 1.91 M 5.56 M 4.45 M 8.40 M
Shareholders' Equity 8.86 M 4.71 M 6.65 M 1.05 M -7.82 M
Total Debt — — — — —
Cash & Equivalents 10.70 M 6.50 M 11.99 M 5.25 M 78,532.0
Current Assets 10.81 M 6.57 M 12.15 M 5.41 M 83,366.0
Current Liabilities 2.00 M 1.91 M 5.56 M 4.45 M 5.49 M